CTKB vs XLV
Cytek Biosciences Inc (CTKB) versus Health Care Select Sector SPDR® Fund (XLV) — a side-by-side from cached financials, not a winner call.
Cytek Biosciences Inc (CTKB) is a medical devices company listed on US.
Health Care Select Sector SPDR® Fund (XLV) common stock listed on US.
Latest reported CTKB revenue for 2026-06-30 was $92.3M. Net income was -$31.0M. CTKB currently screens at market cap $421.8M.
XLV does not have a complete income-statement cache yet.
CTKB currently screens at market cap $421.8M. XLV currently screens at market cap $0.
Not investment advice. Open the CTKB and XLV stock pages for the full models.
Not investment advice.